NCT07163260

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 244 (estimated)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: —
• Healthy volunteers: —

Summary

This study will help to better understand the course of disease in people with haemophilia (A or B \[with or without inhibitors\]) and the haemophilia care scenario in the selected countries and the experience so far in dealing with the condition. This is a survey-based study; hence no medications or other treatments will be provided to participants as a part of this study.

Conditions

• Haemophilia

Interventions

Type	Name	Description
OTHER	No treatment given	No treatment given

Timeline

• Start date: 2025-01-31
• Primary completion: 2025-12-19
• Completion: 2025-12-19
• First posted: 2025-09-09
• Last updated: 2025-10-24

Locations

4 sites across 4 countries: India, Malaysia, South Korea, Thailand